Findings show that cell-free DNA in cerebrospinal fluid can be used to detect measurable residual disease and identify patients at risk of relapse. Scientists at St. Jude Children's Research Hospital ...

It is possible for leukemia to relapse after 20 years. However, it is much more likely for leukemia to relapse in the first few years after the initial diagnosis or remission. Some research reports ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that ...

Multiple sclerosis (MS) is a condition that disrupts the information pathways that connect your brain and your body. From time to time, the symptoms of MS can unexpectedly worsen. When symptoms ...

Stanford Medicine researchers and their colleagues found that a new drug, obexelimab, significantly reduces the risk of ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...

This transcript has been edited for clarity. John Kane, MD: I am Dr John Kane. I am a professor of psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, New ...

• People with mantle cell lymphoma typically experience alternating periods where cancer symptoms lessen or disappear followed by times when the disease returns, with the average symptom-free interval ...